Entero Healthcare Solutions Limited (ENTERO.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-278.4%

-₹2,811.96

vs ₹1,576.00 price

Levered DCF

-₹1,568.99

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
P/E	47.19×	52.94×	92.66×	-432.16×	-167.09×	-322×	5,225.23×
P/B	3.22×	2.91×	2.21×	8.03×	8.91×	10.3×	11.83×
P/S	0.82×	0.99×	0.92×	1.52×	1.99×	2.82×	3.71×
EV / EBITDA	22.35×	24.47×	30.24×	77.91×	203.88×	203.13×	176.77×
Gross margin	5.9%	5.0%	8.9%	8.0%	8.1%	7.6%	8.1%
Operating margin	3.4%	2.8%	2.2%	1.2%	0.2%	0.3%	3.7%
Net margin	1.7%	1.9%	1.0%	-0.4%	-1.2%	-0.9%	0.1%
Current ratio	1.58×	2.46×	3.34×	1.48×	1.84×	2.19×	2.05×
Debt / equity	0.4×	0.23×	0.21×	0.7×	0.63×	0.42×	0.38×
Interest coverage	4.09×	3.38×	1.32×	0.81×	0.16×	0.26×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Return on equity	6.8%	5.5%	2.4%	-1.9%	-5.3%	-3.2%	0.2%
Return on invested capital	7.3%	5.0%	4.4%	4.1%	0.5%	0.8%	2.8%
Return on assets	3.2%	3.5%	1.7%	-0.9%	-2.7%	-1.9%	0.1%
Free cash flow yield	0.0%	-1.8%	-1.2%	-1.0%	-0.9%	-1.6%	-1.6%
Earnings yield	2.1%	1.9%	1.1%	-0.2%	-0.6%	-0.3%	0.0%
Enterprise value	₹59.4B	₹51.7B	₹38.1B	₹54.1B	₹53.1B	₹51.7B	₹51.2B
Net debt / EBITDA	1.94×	0.68×	1.51×	5.94×	11.83×	6.7×	3.99×
Cash conversion cycle (days)	74	79	80	73	83	84	88